| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Sep 30 | S | 123 | $47.01 | $6K | 764,127 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Sep 30 | S | 177 | $47.01 | $8K | 1,050,599 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Sep 30 | S | 57,502 | $46.41 | $2.7M | 764,250 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Sep 30 | S | 83,066 | $46.41 | $3.9M | 1,050,776 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Sep 30 | S | 34,405 | $45.35 | $1.6M | 821,752 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Sep 30 | S | 49,701 | $45.35 | $2.3M | 1,133,842 |
| LAVA Therapeutics NV | LVTX | Versant Venture Capital VI, L.P.10%JOINT | Sep 19 | S | 532,870 | $1.40 | $747KFX | 0 |
| LAVA Therapeutics NV | LVTX | Versant Venture Capital VI, L.P.10%JOINT | Sep 19 | S | 2,370,533 | $1.40 | $3.3MFX | 0 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Sep 18 | S | 132 | $43.30 | $6K | 856,157 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Sep 18 | S | 268 | $43.30 | $12K | 1,183,543 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Sep 18 | S | 20,148 | $43.00 | $866K | 856,289 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Sep 18 | S | 40,907 | $43.00 | $1.8M | 1,183,811 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Sep 18 | S | 24,370 | $41.59 | $1.0M | 876,437 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Sep 18 | S | 49,479 | $41.59 | $2.1M | 1,224,718 |
| LAVA Therapeutics NV | LVTX | Versant Venture Capital VI, L.P.10%JOINT | Sep 18 | S | 228,791 | $1.44 | $330KFX | 532,870 |
| LAVA Therapeutics NV | LVTX | Versant Venture Capital VI, L.P.10%JOINT | Sep 18 | S | 366,111 | $1.44 | $528KFX | 2,370,533 |
| LAVA Therapeutics NV | LVTX | Versant Venture Capital VI, L.P.10%JOINT | Sep 17 | S | 226,726 | $1.49 | $338KFX | 761,661 |
| LAVA Therapeutics NV | LVTX | Versant Venture Capital VI, L.P.10%JOINT | Sep 17 | S | 362,806 | $1.49 | $540KFX | 2,736,644 |
| LAVA Therapeutics NV | LVTX | Versant Venture Capital VI, L.P.10%JOINT | Sep 16 | S | 192,293 | $1.53 | $295KFX | 988,387 |
| LAVA Therapeutics NV | LVTX | Versant Venture Capital VI, L.P.10%JOINT | Sep 16 | S | 307,707 | $1.53 | $472KFX | 3,099,450 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 26 | S | 1,707 | $39.50 | $67K | 900,807 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 26 | S | 3,465 | $39.50 | $137K | 1,274,197 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 26 | S | 21,661 | $38.97 | $844K | 902,514 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 26 | S | 43,978 | $38.97 | $1.7M | 1,277,662 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 25 | S | 1,058 | $39.92 | $42K | 924,175 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 25 | S | 2,149 | $39.92 | $86K | 1,321,640 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 25 | S | 24,760 | $39.53 | $979K | 925,233 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 25 | S | 50,270 | $39.53 | $2.0M | 1,323,789 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 22 | S | 2,809 | $40.59 | $114K | 949,993 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 22 | S | 5,668 | $40.59 | $230K | 1,374,059 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 22 | S | 10,076 | $40.03 | $403K | 952,802 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 22 | S | 20,493 | $40.03 | $820K | 1,379,727 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 18 | S | 15,085 | $38.56 | $582K | 962,878 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 18 | S | 30,628 | $38.56 | $1.2M | 1,400,220 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 15 | S | 69,949 | $39.50 | $2.8M | 977,963 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Aug 15 | S | 145,051 | $39.50 | $5.7M | 1,430,848 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Jul 10 | S | 191,376 | $34.00 | $6.5M | 1,575,899 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Jun 27 | S | 200,000 | $30.47 | $6.1M | 1,767,275 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Jun 20 | S | 133,924 | $30.25 | $4.1M | 1,967,275 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Jun 20 | S | 100,877 | $30.35 | $3.1M | 1,047,912 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Jun 18 | S | 100,000 | $29.95 | $3.0M | 1,148,789 |
| LENZ Therapeutics, Inc. | LENZ | Versant Venture Capital VI, L.P.10%JOINT | Jun 10 | S | 350,000 | $29.00 | $10.2M | 1,248,789 |